Systematic review: the role of the gut microbiota in chemotherapy‐or radiation‐induced gastrointestinal mucositis–current evidence and potential clinical applications

Y Touchefeu, E Montassier, K Nieman… - Alimentary …, 2014 - Wiley Online Library
Background Gastrointestinal mucositis is defined as inflammation and/or ulcers of the
gastrointestinal tract occurring as a complication of chemotherapy and radiation therapy …

Chemotherapy-induced constipation and diarrhea: pathophysiology, current and emerging treatments

RM McQuade, V Stojanovska, R Abalo… - Frontiers in …, 2016 - frontiersin.org
Gastrointestinal (GI) side-effects of chemotherapy are a debilitating and often overlooked
clinical hurdle in cancer management. Chemotherapy-induced constipation (CIC) and …

The Synergistic Effects of Polysaccharides and Ginsenosides From American Ginseng (Panax quinquefolius L.) Ameliorating Cyclophosphamide-Induced Intestinal …

R Zhou, D He, J Xie, Q Zhou, H Zeng, H Li… - Frontiers in …, 2021 - frontiersin.org
Cyclophosphamide (CTX), used in cancer chemotherapy, a high dose of which would cause
immunosuppressive effect and intestinal mucosa damage. American ginseng (Panax …

Chemotherapy‐driven dysbiosis in the intestinal microbiome

E Montassier, T Gastinne, P Vangay… - Alimentary …, 2015 - Wiley Online Library
Background Chemotherapy is commonly used as myeloablative conditioning treatment to
prepare patients for haematopoietic stem cell transplantation (HSCT). Chemotherapy leads …

[HTML][HTML] GDF15 induces anorexia through nausea and emesis

T Borner, ED Shaulson, MY Ghidewon, AB Barnett… - Cell metabolism, 2020 - cell.com
Summary Growth differentiation factor 15 (GDF15) is a cytokine that reduces food intake
through activation of hindbrain GFRAL-RET receptors and has become a keen target of …

Perspectives on cancer therapy‐induced mucosal injury: pathogenesis, measurement, epidemiology, and consequences for patients

ST Sonis, LS Elting, D Keefe… - … Journal of the …, 2004 - Wiley Online Library
BACKGROUND A frequent complication of anticancer treatment, oral and gastrointestinal
(GI) mucositis, threatens the effectiveness of therapy because it leads to dose reductions …

Clinical practice guidelines for the prevention and treatment of cancer therapy–induced oral and gastrointestinal mucositis

EB Rubenstein, DE Peterson… - … Journal of the …, 2004 - Wiley Online Library
BACKGROUND Oral and gastrointestinal (GI) mucositis can affect up to 100% of patients
undergoing high‐dose chemotherapy and hematopoietic stem cell transplantation, 80% of …

Chemotherapy-induced diarrhea: pathophysiology, frequency and guideline-based management

A Stein, W Voigt, K Jordan - Therapeutic advances in …, 2010 - journals.sagepub.com
Diarrhea is one of the main drawbacks for cancer patients. Possible etiologies could be
radiotherapy, chemotherapeutic agents, decreased physical performance, graft versus host …

Emerging evidence on the pathobiology of mucositis

N Al-Dasooqi, ST Sonis, JM Bowen, E Bateman… - Supportive care in …, 2013 - Springer
Background Considerable progress has been made in our understanding of the biological
basis for cancer therapy-induced mucosal barrier injury (mucositis). The last formal review of …

Manipulations of the gut microbiome alter chemotherapy-induced inflammation and behavioral side effects in female mice

CV Grant, BR Loman, MT Bailey, LM Pyter - Brain, behavior, and immunity, 2021 - Elsevier
Chemotherapy treatment is associated with acute behavioral side effects (fatigue, anorexia)
that significantly reduce patient quality of life and are dose-limiting, thereby increasing …